期刊文献+

白细胞蛋白酶抑制因子促进真皮间充质干细胞增殖的机制 被引量:4

Mechanism of secretory leukocyte protease inhibitor promoting proliferation of dermal mesenchyreal stem cells
原文传递
导出
摘要 目的研究白细胞蛋白酶抑制因子(secretory leukocyte protease inhibitor,SLPI)对真皮间充质干细胞(dermal mesenchymal stem cells,dMSCs)的增殖作用及其机制。方法利用贴壁生长的特性分离dMSCs,细胞在无血清IMDM培养液中培养48h后,加入不同浓度的SLPI,24h后加入[H^3]Thymidine,通过液闪计数器计数。提取对照组和SLPI作用后细胞的总RNA和蛋白,反转录-聚合酶链反应(RT—PCR)检测SLPI因子作用前后cyclin A、CDK2、CDK4的变化,Western blot检测SLPI因子作用前后cyclin D1、cyclin E的表达变化。结果分离的大鼠dMSCs呈梭形.在体外显示多向分化潜能。加入SLPI因子后,[H^3]Thymidine掺人活性增强。RT—PCR提示在SLPI诱导下,CDK2表达增强,而cyclin A和CDK4表达没有明显变化,Western blot提示SLPI因子作用后cyclin DI、cyclin E表达均明显增强。结论SLPI能够促进dMSCs的增殖,其机制可能是通过调节cychn D1、cyclin E、CDK2等细胞周期素的表达。 Objective To investigate the role of SLPI (secretory leukocyte protease inhibitor) in promoting proliferation of dMSCs as well as related mechanisms. Methods dMSCs were isolated from the rat skin tissues and cultured in serum-free IMDM medium for 48 hours. Then the cells were labeled with[ H^3 ] thymidine and the radioactivity was measured by automatic liquid scintillation counter. After the stimulation by SLPI, the expressions of cyclin A, cdk2 and cdk4 in dMSCs were determined by RT-PCR and the expressions of cyclin D1 and cyclinE were investigated using western-blot analysis. Results Most of the neonatal dMSCs were spindle-shaped cells and exhibited multilineage potential in vitro. A concentration-dependent proliferation promotion was demonstrated in dMSCs incubated with SLPI, compared with the control groups. The results from RT-PCR experiment indicated that this stimulation by SLPI increased the expression of cdk2, but had no effects on the expressions of cyclinA and cdk4. Mean- while, the western-blot analysis showed the increase of the expressions of cyclinD and cyclin E at the level of protein after SLPI stimulation. Conclusion SLPI can support the growth of dMSCs in serum-free medium in vitro. The molecular mechanism underlying this function may relate to the modulation of cell cycle progression via regulating cyclin DI, cyclin E and cdk2 expressions.
出处 《中华创伤杂志》 CAS CSCD 北大核心 2007年第3期235-238,共4页 Chinese Journal of Trauma
基金 国家自然科学基金项目资助(30370562) 国家重点基础研究发展规划资助项目(2005CB522605)
关键词 干细胞 白细胞蛋白酶抑制因子 增殖 Stem ceils Secretory leukocyte protease inhibitor Proliferation
  • 相关文献

参考文献10

  • 1Doumas S, Kolokotronis A, Stefanopoulos P. Anti - inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor. Infect Immun, 2005, 73: 1271 - 1274.
  • 2史春梦,程天民.创伤局部微环境对大鼠真皮多能干细胞生物学性状的影响[J].中华创伤杂志,2003,19(4):199-202. 被引量:8
  • 3Devoogdt N, Revets H, Ghassabeh GH, et al. Secretory leukocyte protease inhibitor in cancer development. Ann N Y Acad Sci, 2004,1028:380 - 389.
  • 4Goselink HM, van - Damme J, Hiemstra PS, et al. Colony growth of human hematopoietic progenitor cells in the absence of serum is supported by a proteinase inhibitor identified as antileukoproteinase. J Exp Med, 1996, 184:1305 -1312.
  • 5Kikuchi T, Abe T, Yaekashiwa M, et al. Secretory leukoprotease inhibitor augments hepatocyte growth factor production in human lung fibroblasts. Am J Respir Cell Mol Biol, 2000, 23:364 -370.
  • 6Zhang D, Simmen RC, Michel FJ, et al. Secretory leukocyte protease inhibitor mediates proliferation of human endometrial epithelial cells by positive and negative regulation of growth - associated genes. J Biol Chem, 2002, 277:29999-30009.
  • 7Devoogdt N, Hassanzadeh GG, Zhang J, et al. Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells. Proc Natl Acad Sci, 2003, 100:5778 -5782.
  • 8Kincade PW, Oritani K, Zheng Z, et al. Cell interaction molecules utilized in bone marrow. Cell Adhes Commun, 1998, 6:211 -215.
  • 9Bergsagel PL, Kuehl WM, Zhan F, et al. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood,2005, 106:296 - 303.
  • 10Aleem E, Kiyokawa H, Kaldis P. Cdc2 -cyclin E complexes regulate the G1/S phase transition. Nat Cell Biol, 2005, 7:779- 781.

二级参考文献1

共引文献7

同被引文献44

  • 1江德鹏,向静,文亮,粟永萍,屈纪富,冉新泽.白细胞蛋白酶抑制因子在真皮多能干细胞中的表达[J].中国急救医学,2006,26(5):345-348. 被引量:2
  • 2江德鹏,向静,文亮,粟永萍,屈纪富,冉新泽.创伤修复中白细胞蛋白酶抑制因子和中性粒细胞趋化因子差异表达的研究[J].第三军医大学学报,2006,28(17):1742-1745. 被引量:3
  • 3屈纪富,江德鹏,郑怀恩,郝利,文亮,程天民.创伤早期伤口液对体外培养真皮多能干细胞增殖迁移特性的影响[J].第三军医大学学报,2006,28(24):2393-2395. 被引量:6
  • 4Velarde MC, Parisek SI, Eason RR, et al. The secretory leukocyte protease inhibitor gene is a target of epidermal growth factor receptor action in endometrial epithelial cells [ J ]. J Endocrinol, 2005, 184(1) :141 -151.
  • 5Simpkins FA, Devoogdt NM, Rasool N, et al. The alarm anti-protease, secretory leukocyte protease inhibitor, is a proliferation and survival factor for ovarian cancer cells [ J ]. Carcinogenesis, 2008,29 (3) :466 -472.
  • 6Angelov N, Moutsopoulos N, Jeong M J, et al. Aberrant mucosal wound repair in the absence of secretory leukocyte protease inhibitor[ J]. Thromb Haemost,2004,92 (2) :288 - 297.
  • 7Nukiwa T,Suzuki T, Fukuhara T, et al. Secretory leukocyte peptidase inhibitor and lung cancer[ J]. Cancer Sci,2008,99 (5) :849 - 855.
  • 8Shugars DC, Alexander AL, Fu K, et al. Endogenous salivary inhibitors of human immunodeliciency virus[ J]. Arch Oral Biol, 1999,44 (6) :445 -453.
  • 9Urso ML, Chen YW, Scrimgeour AG, et al. Alterations in mRNA expression and protein products following spinal cord injury in humans [ J]. J Physiol,2007,579 ( Pt 3 ) :877 - 892.
  • 10Ashcroft GS, Lei K, Jin W, et al. Secretory leukocyte protease inhibitor mediates non - redundant functions necessary for normal wound healing[ J]. Nat Med ,2000,6 (10) : 1147 - 1153.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部